IMPLEMENTATION OF PROPOSALS FOR MANAGEMENT OF ATHEROGENIC DYSLIPIDEMIA IN PRIMARY CARE. RESULTS OF THE DAT-AP STUDY.

Angel Díaz Rodríguez, Adalberto Serrano Cumplido, Jesús Millán Nuñez-Cortés, Mª Luisa Orera Peña, Marta Rodríguez de Miguel*

ABSTRACT

Background and aims: The ―DAT-AP‖ (from the Spanish, ―Dislipemia ATerogénica en Atención Primaria‖, for Atherogenic Dyslipidaemia in Primary Care) study aims to understand the level of inculcation of knowledge on the diagnosis and treatment of Atherogenic Dyslipidaemia in the scope of Primary Care, according to the consensus recommendations published previously. Methods: This is a national, multicentre, cross-sectional study, in which 991 Primary Care doctors recorded, in an online computer application, certain characteristics of their clinical practice related to atherogenic dyslipidaemia, particularly in the aspects of: atherogenic dyslipidaemia epidemiology and medical impact, association with cardiovascular risk, detection of atherogenic dyslipidaemia, treatment objectives and therapeutic approach. Results: The results can be considered to be reasonably satisfactory as regards the implementation of criteria reached as a consensus for the diagnostic and therapeutic management of atherogenic dyslipidaemia. This includes over 90% of the participants considering the process highly relevant and worthy of attention. However, the consideration of hypertriglyceridemia or low HDL-C as isolated cardiovascular risk factors or the therapeutic approach when these alterations are present merit strategies to reinforce the available scientific evidence; particularly on the benefit of treatment with fibrates, in combination with statins or not.

Keywords: Atherogenic dyslipidaemia; residual risk; primary care.